Serum γ-Glutamyltransferase and Risk of Metabolic Syndrome and Type 2 Diabetes in Middle-Aged Japanese Men

OBJECTIVE —To investigate the association between serum γ-glutamyltransferase (GGT) and risk of metabolic syndrome and type 2 diabetes in Japanese male office workers. RESEARCH DESIGN AND METHODS —This study included 2,957 metabolic syndrome-free men and 3,260 nondiabetic men aged 35–59 years who did not have medication for hepatitis, alanine aminotransferase (ALT) levels higher than three times the upper limit of the reference range, or a history of cardiovascular disease at study entry. Subjects were reexamined at periodic annual health examinations over a 7-year period. We used a modified National Cholesterol Education Program definition of metabolic syndrome with BMI instead of waist circumference and the revised criteria of the American Diabetes Association for type 2 diabetes. RESULTS —With adjustment for age, family history of diabetes, BMI, alcohol intake, cigarette smoking, regular physical activity (fasting plasma glucose for the risk of type 2 diabetes), and white blood cell (WBC) count, the risk of metabolic syndrome and type 2 diabetes increased in correlation with the levels of serum GGT, ALT, aspartate aminotransferase (AST), and alkaline phosphatase. Additional adjustment for all of the other liver enzymes attenuated these associations, but serum GGT remained a significant risk factor for the risk of both metabolic syndrome and type 2 diabetes ( P for trend CONCLUSIONS —These results indicate that serum GGT may be an important predictor for developing metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

[1]  A. Rantala,et al.  Gamma‐glutamyl transpeptidase and the metabolic syndrome , 2000, Journal of internal medicine.

[2]  K. Tatara,et al.  Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. , 2003, Diabetes care.

[3]  C. Packard,et al.  Associations of indices of adiposity with atherogenic lipoprotein subfractions , 1998, International Journal of Obesity.

[4]  C. Lewis,et al.  γ-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2003 .

[5]  O H Førde,et al.  The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase. , 1990, American journal of epidemiology.

[6]  A. Stark.  Oxidative metabolism of glutathione by gamma-glutamyl transpeptidase and peroxisome proliferation: the relevance to hepatocarcinogenesis. A hypothesis. , 1991, Mutagenesis.

[7]  Paul M. Ridker,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003 .

[8]  S. Ebrahim,et al.  Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. , 1995, American journal of epidemiology.

[9]  G. Hotamisligil,et al.  Inflammatory pathways and insulin action , 2003, International Journal of Obesity.

[10]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[11]  J. Whitfield.  Gamma Glutamyl Transferase , 2001, Critical reviews in clinical laboratory sciences.

[12]  J. Pankow,et al.  Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. , 2001, Obesity research.

[13]  W. Hsueh,et al.  Role of endothelial dysfunction in insulin resistance. , 2003, The American journal of cardiology.

[14]  G. Marchesini,et al.  NASH: From liver diseases to metabolic disorders and back to clinical hepatology , 2002, Hepatology.

[15]  S. Wannamethee,et al.  Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM , 1998, Diabetes Care.

[16]  P. Elwood,et al.  γ-Glutamyltransferase and risk of stroke: the EUROSTROKE project , 2002, Journal of epidemiology and community health.

[17]  S. Haffner,et al.  Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study. , 1997, Obesity research.

[18]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[19]  S. Malnick,et al.  Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. , 2003, QJM : monthly journal of the Association of Physicians.

[20]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[21]  T. Rabelink,et al.  Postprandial recruitment of neutrophils may contribute to endothelial dysfunction Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.M200419-JLR200 , 2003, Journal of Lipid Research.

[22]  K. Suzuki,et al.  Serum γ‐glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle‐aged Japanese men , 2003, Journal of internal medicine.